Elizabeth Hansell

University of California, San Francisco

Papers

1

Total Citations

296

H-Index

1

About

Dr. Elizabeth Hansell is a leading researcher in antiparasitic drug design, with a primary focus on cysteine proteases of the papain superfamily—enzymes that serve as critical virulence factors in parasitic diseases. Her most influential work, the 2009 study "Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design," has garnered 296 citations and established a structural framework for targeting these enzymes. By elucidating the crystal structures of three major parasitic cysteine proteases, Hansell provided the molecular blueprint for developing vinyl sulfone-based inhibitors, a class of compounds now recognized as promising antiparasitic agents. Her contributions bridge structural biology and medicinal chemistry, offering a rational approach to combat diseases such as Chagas, leishmaniasis, and African sleeping sickness. With a career marked by high-impact publications and a sustained focus on translating enzyme structure into therapeutic strategy, Hansell has become a pivotal figure in the fight against neglected tropical diseases. Her work not only advances fundamental understanding of parasite biology but also directly informs the design of next-generation antiparasitic drugs.

Research Focus

Key Achievements

1
H-Index
1
Papers
296
Total Citations
296
Avg Citations/Paper
🏆 Most Cited Paper
Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design
296 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago